The average one-year price target for ProKidney (NasdaqCM:PROK) has been revised to $6.85 / share. This is an increase of 15.10% from the prior estimate of $5.95 dated December 3, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $1.01 to a high of $12.60 / share. The average price target represents an increase of 188.97% from the latest reported closing price of $2.37 / share.
What is the Fund Sentiment?
There are 121 funds or institutions reporting positions in ProKidney. This is an increase of 13 owner(s) or 12.04% in the last quarter. Average portfolio weight of all funds dedicated to PROK is 0.02%, an increase of 165.56%. Total shares owned by institutions increased in the last three months by 179.68% to 37,294K shares. 
The put/call ratio of PROK is 0.31, indicating a bullish outlook.
What are Other Shareholders Doing?
Suvretta Capital Management holds 12,341K shares representing 8.72% ownership of the company.
Bleichroeder holds 2,000K shares representing 1.41% ownership of the company.
Millennium Management holds 1,956K shares representing 1.38% ownership of the company.
VEXMX - Vanguard Extended Market Index Fund Investor Shares holds 1,375K shares representing 0.97% ownership of the company. No change in the last quarter.
FSSNX - Fidelity Small Cap Index Fund holds 1,130K shares representing 0.80% ownership of the company. In its prior filing, the firm reported owning 1,043K shares , representing an increase of 7.69%. The firm decreased its portfolio allocation in PROK by 33.34% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
